![]() Why would you want a CEO who can’t provide information to shareholders in an appropriate manner? The real issue here is nobody can ever figure out what Nader says. They did, and it will happen tomorrow night. Donald Borsie asks, “When is the meeting date with the Philippines group going to take place, and did the Philippines request the meeting?” But we will update you as soon as we have something. So I want everyone to know that we are at the very close position to hopefully have some major thing breakthrough for us in Philippine, but I just cannot get into any of the details until we get there because this is just very confidential stuff. Has the company been in any discussion with the Filipino FDA to release that data? And have they provided any confidential data that is supportive of other trials?” Jaydon Shields says, “Twenty-eight Filipino CSP patients were dosed this year. So we are getting ready for the next PO, and we think this is going to pick up even more. And they are interested again to look at this for a second time, the regulatory agency.Īnd the last PO that we talked about just a few days ago in our conference call is already consumed and used already. Other VIP patients also, and other patients who are as important as them, also their lives got saved.īut now we have a fantastic situation again where we are going in front of a committee and presenting our results. ![]() So the situation that we have with Philippine, as everyone knows, as we started giving leronlimab under Compassionate Special Permit for fee (we charge patients over there) the story that start coming out: the ex-president of Philippine, lives were saved, they thank us for that. We now have received an additional PO from Chiral pharma for the Philippines and momentum is starting to build up again. The previous PO was not released for about 4 weeks from the customs. Many more testimonies are coming from people who used leronlimab in Philippines. Family member of a key political official has been treated with leronlimab and has recovered and released from the hospital. And they are interested again to look at this for a second time, the regulatory agency.” (See minute 16 below.) “But now we have a fantastic situation again where we are going in front of a committee and presenting our results. ![]() I certainly interpreted it as meaning that the meeting was with the Philippines “regulatory agency.” Upon transcribing it, I see that he was not clear, as usual, and did not specifically state that. ![]() This is what was said at the Emerging Growth Conference re the Philippines. We are trying our best to compile the results from the Philippines so that Cytodyn, Inc can have more data to support leronlimab’s efficacy against severe critical COVID. Recently, a lot more doctors and hospitals are asking for leronlimab as well! Hence the additional PO’s. The US FDA public rebuke really put the brakes on the use of leronlimab here in the Philippines but you cant argue with a patient who walks out of the hospital, so more and more patients are asking for leronlimab. I believe what he meant was that we will be having another webinar with a major hospital in the Philippines which will include the therapeutics committee of the hospital. ![]() Sorry been a hectic 2 months, I’m afraid NP was taken out of context during the investor conference. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |